Blog

This May, we visited the Navajo Nation to mark the opening of the first full-time cancer center on an American Indian Reservation. Since then, two major media companies spotlighted our work with the Navajo Nation and health leaders to create the first full-time cancer care center on an American Indian reservation.

On Sunday, June 9 as part of the 73 rd annual Tony Awards, we will have the opportunity to celebrate the legacy of a great champion for cancer patients and their loved ones. The late CSC Champion and three-time Tony Award nominee and 2017 American Theatre Hall of Fame Inductee Marin Mazzie will be honored with a special Tony Award in recognition of her leadership within the theatre community for women’s health issues and her support of organizations such as the Cancer Support Community.

Medicare Part D is a voluntary outpatient prescription drug benefit to assist people in affording their prescription medications. Part D benefits are provided through private health insurance plans and approved by the federal government. Participants in Part D are able to choose between supplementing their traditional Medicare with a stand-alone prescription drug plan or a Medicare Advantage prescription drug plan that is part of and includes other aspects of Medicare. In November, 2018 the Centers for Medicare & Medicaid Services (CMS) proposed a new rule for Part D that would have changed the special coverage protections for medications included in the six protected classes.

Leaders of the Navajo Nation, the Tuba City Regional Health Care Corporation (TCRHCC), and the Cancer Support Community (CSC) joined Dr. Jill Biden on the Navajo Nation in marking a milestone moment: the opening of the first full-time cancer care center on an American Indian Reservation.

Endometrial cancer— a type of uterine cancer that forms in the tissue lining of the uterus—is one of the most common cancers in American women, yet many populations, including Hispanic women, lack the necessary information to recognize risk factors.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our featured advocate for April, 2019, and her advice for overcoming fears and jumping into advocacy. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!

While a cancer diagnosis during pregnancy is rare, it does occur. Read our short Q-and-A on what to know about treatment during pregnancy.

On March 22nd, 2019 the Research and Training Institute (RTI) presented findings from two studies at the National Comprehensive Cancer Network (NCCN) Annual Conference in Orlando, FL. Below is a post from the research team about the significance of their findings from one study for people diagnosed with cancer, their families, and cancer care providers.

On March 6th, 2019 our Research and Training Institute (RTI) presented findings of a study on more than 40 adult patients with a diagnosis of melanoma at the Society of Behavioral Medicine’s 40th Annual Meeting and Scientific Sessions. Below is a post from the research team about the significance of their findings for the melanoma community.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our featured advocate for March, 2019, and her inspiring story and engagement with advocacy at CSC and beyond. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!